UT Code § 4-41a-102 (2021)
2021 Utah Code|Title 4 - Utah Agricultural Code|Chapter 41a - Cannabis Production Establishments|Part 1 - General Provisions|Section 102 - Definitions.

 Effective 3/17/2021  4-41a-102. Definitions.  As used in this chapter:  (1) "Adulterant" means any poisonous or deleterious substance in a quantity that may be injurious to health, including:   (a) pesticides;     (b) heavy metals;     (c) solvents;     (d) microbial life;     (e) toxins; or     (f) foreign matter.       (2) "Cannabinoid Product Board" means the Cannabinoid Product Board created in Section 26-61-201.     (3) "Cannabis" means the same as that term is defined in Section 26-61a-102.     (4) "Cannabis concentrate" means:   (a) the product of any chemical or physical process applied to naturally occurring biomass that concentrates or isolates the cannabinoids contained in the biomass; and     (b) any amount of a natural, derivative, or synthetic cannabinoid in the synthetic cannabinoid's purified state.       (5) "Cannabis cultivation byproduct" means any portion of a cannabis plant that is not intended to be sold as a cannabis plant product.     (6) "Cannabis cultivation facility" means a person that:   (a) possesses cannabis;     (b) grows or intends to grow cannabis; and     (c) sells or intends to sell cannabis to a cannabis cultivation facility, a cannabis processing facility, or a medical cannabis research licensee.       (7) "Cannabis cultivation facility agent" means an individual who:   (a) is an employee of a cannabis cultivation facility; and     (b) holds a valid cannabis production establishment agent registration card.       (8) "Cannabis derivative product" means a product made using cannabis concentrate.     (9) "Cannabis plant product" means any portion of a cannabis plant intended to be sold in a form that is recognizable as a portion of a cannabis plant.     (10) "Cannabis processing facility" means a person that:   (a) acquires or intends to acquire cannabis from a cannabis production establishment;     (b) possesses cannabis with the intent to manufacture a cannabis product;     (c) manufactures or intends to manufacture a cannabis product from unprocessed cannabis or a cannabis extract; and     (d) sells or intends to sell a cannabis product to a medical cannabis pharmacy or a medical cannabis research licensee.       (11) "Cannabis processing facility agent" means an individual who:   (a) is an employee of a cannabis processing facility; and     (b) holds a valid cannabis production establishment agent registration card.       (12) "Cannabis product" means the same as that term is defined in Section 26-61a-102.     (13) "Cannabis production establishment" means a cannabis cultivation facility, a cannabis processing facility, or an independent cannabis testing laboratory.     (14) "Cannabis production establishment agent" means a cannabis cultivation facility agent, a cannabis processing facility agent, or an independent cannabis testing laboratory agent.     (15) "Cannabis production establishment agent registration card" means a registration card that the department issues that:   (a) authorizes an individual to act as a cannabis production establishment agent; and     (b) designates the type of cannabis production establishment for which an individual is authorized to act as an agent.       (16) "Community location" means a public or private elementary or secondary school, a church, a public library, a public playground, or a public park.     (17) "Cultivation space" means, quantified in square feet, the horizontal area in which a cannabis cultivation facility cultivates cannabis, including each level of horizontal area if the cannabis cultivation facility hangs, suspends, stacks, or otherwise positions plants above other plants in multiple levels.     (18) "Delta-9-tetrahydrocannabinol" or "delta-9-THC" means the cannabinoid identified as CAS# 1972-08-03, the primary psychotropic cannabinoid in cannabis.     (19) "Department" means the Department of Agriculture and Food.     (20) "Derivative cannabinoid" means any cannabinoid that has been intentionally created using a process to convert a naturally occurring cannabinoid into another cannabinoid.     (21) "Family member" means a parent, step-parent, spouse, child, sibling, step-sibling, uncle, aunt, nephew, niece, first cousin, mother-in-law, father-in-law, brother-in-law, sister-in-law, son-in-law, daughter-in-law, grandparent, or grandchild.     (22)   (a) "Independent cannabis testing laboratory" means a person that:   (i) conducts a chemical or other analysis of cannabis or a cannabis product; or     (ii) acquires, possesses, and transports cannabis or a cannabis product with the intent to conduct a chemical or other analysis of the cannabis or cannabis product.       (b) "Independent cannabis testing laboratory" includes a laboratory that the department operates in accordance with Subsection 4-41a-201(14).       (23) "Independent cannabis testing laboratory agent" means an individual who:   (a) is an employee of an independent cannabis testing laboratory; and     (b) holds a valid cannabis production establishment agent registration card.       (24) "Industrial hemp waste" means:   (a) a cannabinoid extract above 0.3% total THC derived from verified industrial hemp biomass; or     (b) verified industrial hemp biomass with a total THC concentration of less than 0.3% by dry weight.       (25) "Inventory control system" means a system described in Section 4-41a-103.     (26) "Licensing board" or "board" means the Cannabis Production Establishment Licensing Advisory Board created in Section 4-41a-201.1.     (27) "Medical cannabis" means the same as that term is defined in Section 26-61a-102.     (28) "Medical cannabis card" means the same as that term is defined in Section 26-61a-102.     (29) "Medical cannabis pharmacy" means the same as that term is defined in Section 26-61a-102.     (30) "Medical cannabis pharmacy agent" means the same as that term is defined in Section 26-61a-102.     (31) "Medical cannabis research license" means a license that the department issues to a research university for the purpose of obtaining and possessing medical cannabis for academic research.     (32) "Medical cannabis research licensee" means a research university that the department licenses to obtain and possess medical cannabis for academic research, in accordance with Section 4-41a-901.     (33) "Medical cannabis treatment" means the same as that term is defined in Section 26-61a-102.     (34) "Medicinal dosage form" means the same as that term is defined in Section 26-61a-102.     (35) "Qualified medical provider" means the same as that term is defined in Section 26-61a-102.     (36) "Qualified Production Enterprise Fund" means the fund created in Section 4-41a-104.     (37) "Recommending medical provider" means the same as that term is defined in Section 26-61a-102.     (38) "Research university" means the same as that term is defined in Section 53B-7-702 and a private, nonprofit college or university in the state that:   (a) is accredited by the Northwest Commission on Colleges and Universities;     (b) grants doctoral degrees; and     (c) has a laboratory containing or a program researching a schedule I controlled substance described in Section 58-37-4.       (39) "State electronic verification system" means the system described in Section 26-61a-103.     (40) "Synthetic cannabinoid" means any cannabinoid that:   (a) was chemically synthesized from starting materials other than a naturally occurring cannabinoid; and     (b) is not a derivative cannabinoid.       (41) "Tetrahydrocannabinol" means a substance derived from cannabis or a synthetic equivalent as described in Subsection 58-37-4(2)(a)(iii)(AA).     (42) "Total composite tetrahydrocannabinol" means all detectable forms of tetrahydrocannabinol.     (43) "Total tetrahydrocannabinol" or "total THC" means the sum of the determined amounts of delta-9-THC and tetrahydrocannabinolic acid, calculated as "total THC = delta-9-THC + (THCA x 0.877)."    Amended by Chapter 337, 2021 General SessionAmended by Chapter 350, 2021 General Session